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L E T T E R
Sotos syndrome and the added value of genetic workup in 
epilepsy surgery
To the editors,
We read with great interest the study by Fortin et al1 describ-
ing the phenotypic spectrum of seizures and epilepsy in 49 
patients with Sotos syndrome based on a structured clinical 
interview and chart review. The authors report patients’ sei-
zure semiologies, with more than two- thirds showing “staring 
spells,” half showing afebrile generalized tonic- clonic seizures 
and half having a history of febrile convulsions. In line with 
previous reports,2 seizures in these patients usually respond to 
antiseizure drug treatment, with only a small fraction of pa-
tients having a drug- resistant epilepsy. The high prevalence 
of “staring spells” by Fortin et al1 suggests a high incidence 
of focal seizures with impaired awareness. Yet, no potentially 
epileptogenic focal lesions were noted on neuroimaging. Focal 
seizures, often with temporal lobe semiology and ictal EEG 
patterns, have previously been noted in patients with Sotos 
syndrome by Nicita et al,2 similarly without associated struc-
tural brain lesions. However, Sotos syndrome is associated 
with a 2%– 3% risk of malignancy.3 Most commonly, these 
comprise lympho- hematological tumors, but can very rarely 
include potential epileptogenic low- grade brain tumors.4,5
We have recently reported a challenging case6 of drug- 
resistant epilepsy with temporal lobe seizures evolving into 
bilateral tonic- clonic seizures in the presence of a mesio-
temporal brain tumor in a boy with developmental delay and 
overgrowth. Because of the focal- onset epilepsy associated 
with a low- grade neuroepithelial tumor, our patient under-
went presurgical evaluation and subsequent epilepsy surgery. 
Histopathology confirmed a diffuse astrocytoma, but its 
gross- total resection failed to control the seizures. Genetic 
testing performed during the reevaluation of this case of un-
successful epilepsy surgery identified an NSD1 pathogenic 
variant, thus establishing the diagnosis of Sotos syndrome.
Our case turns the spotlight on this rare, potentially mis-
leading presentation of Sotos syndrome. Here, a focal epilep-
togenic brain lesion did not fully explain the clinical picture 
of focal seizures associated with dysmorphic features and 
medical comorbidities and an unsuccessful epilepsy surgery 
ultimately led to the unifying diagnosis of Sotos syndrome.
In the context of the case series presented by Fortin et al,1 
which indicates that patients with seizures and Sotos syn-
drome have favorable outcomes in terms of seizure control, 
our case clearly represents a rare exception in terms of poor 
seizure control. Yet, the rarer cases of drug- resistant epilepsy 
in Sotos syndrome can pose important diagnostic challenges 
that should be taken into account. Our case thus highlights 
Sotos syndrome as an important differential for drug- resistant 
epilepsy in the context of an overgrowth syndrome. Most 
importantly, our case underlines the importance of genetic 
testing as part of presurgical workup in drug- resistant focal 
epilepsy, even in apparently straightforward cases of lesional 
epilepsy, to rule out an underlying genetic substrate that may 
preclude surgical success.
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